<DOC>
	<DOCNO>NCT02429830</DOCNO>
	<brief_summary>The purpose study evaluate LINX device patient previously undergone laparoscopic sleeve gastrectomy ( LSG ) obesity chronic gastroesophageal reflux disease ( GERD ) . The study monitor safety change reflux symptom .</brief_summary>
	<brief_title>A Study Reflux Management With LINX® System Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>INCLUSION CRITERIA Subjects include study must meet following criterion : 1 . Age &gt; 22 year 2 . Laparoscopic sleeve gastrectomy ( LSG ) obesity &gt; 12 month prior propose device implantation date . 3 . Subject surgical candidate , i.e . able undergo general anesthesia laparoscopic surgery . 4 . Documented typical symptom GERD longer 6 month ( regurgitation heartburn define burn epigastric substernal pain responds acid neutralization suppression ) . 5 . Subject require daily proton pump inhibitor antireflux drug therapy . 6 . Total distal ambulatory esophageal pH must meet following criterion : pH &lt; 4 &gt; 4.5 % time . Note : Subjects shall discontinue GERD medication least 7 day prior test , exception antiacid morning testing . 7 . Subjects symptomatic improvement PPI therapy demonstrate GERDHRQL score &lt; 10 PPI &gt; 15 PPI , subject &gt; 6 point improvement compare PPI PPI GERDHRQL score . 8 . GERD symptom , absence PPI therapy ( minimum 7 day ) . 9 . If subject child bear potential must negative pregnancy test within one week prior implant must agree use effective mean birth control course study . 10 . Subject willing able cooperate followup examination 11 . Subject inform study procedure treatment sign informed consent form . EXCLUSION CRITERIA Subjects exclude study base follow criterion : 1 . The procedure emergency procedure . 2 . Suspected known allergy titanium , stainless steel , nickel , ferrous material . 3 . Presence ˃3 cm hiatal hernia determine endoscopy barium esophagram . 4 . Subject major complication relate laparoscopic sleeve gastrectomy may interfere , increase risk LINX procedure ( , limit , leak gastric remnant infection sleeve gastrectomy ) 5 . Plans surgically revise gastric pouch ( either know preoperatively decide intraoperatively ) 6 . Currently treat another investigational drug investigational device . 7 . Suspected confirmed esophageal gastric cancer prior gastric esophageal surgery endoscopic intervention GERD ( exception sleeve gastrectomy ) . 8 . Distal amplitude &lt; 35 mmHg &lt; 70 % peristaltic sequence . 9 . Presence esophagitis Grade C D ( LA Classification ) . 10 . BMI &gt; 35 . 11 . Symptoms dysphagia per week within last 3 month . 12 . Diagnosed Scleroderma . 13 . Diagnosed esophageal motility disorder limit achalasia , nutcracker esophagus , diffuse esophageal spasm hypertensive LES . 14 . Subject history know esophageal stricture gross esophageal anatomic abnormality ( Schatzki 's ring , obstructive lesion , etc . ) 15 . Subject esophageal gastric varix 16 . History of/or know Barrett 's esophagus . Note : The diagnosis Barrett 's esophagus require endoscopic histologic evidence metaplastic columnar epithelium . Endoscopically , must columnar epithelium within esophagus . Histologically , epithelium must metaplastic , define presence goblet cells.by 17 . Subject understand trial requirement unable comply followup schedule 18 . Pregnant nursing , plan become pregnant course study . 19 . Any reason Investigator believe may cause subject noncompliant unable meet protocol requirement . 20 . Subject electrical implant metallic , abdominal implant .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>gastroesophageal reflux disease</keyword>
	<keyword>GERD</keyword>
	<keyword>obesity</keyword>
	<keyword>LSG</keyword>
	<keyword>Laparoscopic Sleeve Gastrectomy</keyword>
</DOC>